KRAS and pancreatic adenocarcinoma: Autophagy inhibition combined with the absence of p53 increases the tumorigenic capabilities of K-Ras driven cells, as determined by lower overall survival of mice with pancreatic adenocarcinoma (Rosenfeldt et al., 2013; White, 2016).